Monday to Friday: 10:00 AM to 6:00 PM Saturday: 10:00 AM to 5:00 PM
This benefit makes it an attractive choice for patients struggling with obesity, often an accompanying issue in type 2 diabetes
Tapering (gradually lowering your dose over weeks) is not typically necessary with semaglutide, as the medication is cleared relatively quickly from your system after each injection
It is important to note that Rybelsus is not designed for type 1 diabetes
This powerful combination decreases appetite by signaling fulness and satisfaction to your brain
In a head-to-head trial in adults with obesity or overweight without diabetes, tirzepatide, the active ingredient in Mounjaro and Zepbound led to greater average weight loss than semaglutide over 72 weeks.However, there are various factors to consider when determining which medication is the best fit for an individual's unique needs including cost and insurance coverage, overall health, side effects, and how well the medication aligns with one's lifestyle and goals